In vitro antiviral and immunomodulatory activity of arbidol and structurally related derivatives in herpes simplex virus type 1-infected human keratinocytes (HaCat)
Arbidol (ARB) is an antiviral drug that has broad-spectrum activity against a number of viral infections. To date, there are no specific data regarding its effects against a herpesvirus. Here, the in vitro antiviral effect of ARB and structurally related derivatives were evaluated in HaCat cells on different steps of herpes simplex virus type 1 replication: adsorption, entry and post-entry. The simplified pyrrolidine analogue, 9a2, showed the best antiviral activity in vitro by reducing the plaque numbers by about 50 % instead of 42 % obtained with ARB at the same concentration. Furthermore, we have reported that all tested compounds evaluated for their immunomodulatory activity showed the ability to reduce the viral proteins VP16 and ICP27 and to modify the virus-induced cytokine expression, allowing the host cell a more efficient antiviral response.
BoriskinY. S., LenevaI. A., PécheurE. I., PolyakS. J.2008; Arbidol: a broad-spectrum antiviral compound that blocks viral fusion. Curr Med Chem 15:997–1005 [View Article][PubMed]
BrancatoV., PedutoA., WhartonS., MartinS., MoreV., Di MolaA., MassaA., PerfettoB., DonnarummaG.& other authors (2013; Design of inhibitors of influenza virus membrane fusion: synthesis, structure-activity relationship and in vitro antiviral activity of a novel indole series. Antiviral Res 99:125–135 [View Article][PubMed]
BrooksM. J., SasadeuszJ. J., TannockG. A.2004; Antiviral chemotherapeutic agents against respiratory viruses: where are we now and what’s in the pipeline?. Curr Opin Pulm Med 10:197–203 [View Article][PubMed]
DeloguI., PastorinoB., BarontiC., NougairèdeA., BonnetE., de LamballerieX.2011; In vitro antiviral activity of arbidol against Chikungunya virus and characteristics of a selected resistant mutant. Antiviral Res 90:99–107 [View Article][PubMed]
DonnarummaG., De GregorioV., FuscoA., FarinaE., BaroniA., EspositoV., ContaldoM., PetruzziM., PannoneG., SerpicoR.2010; Inhibition of HSV-1 replication by laser diode-irradiation: possible mechanism of action. Int J Immunopathol Pharmacol 23:1167–1176[PubMed]
FilosaR., PedutoA., de CaprariisP., SaturninoC., FestaM., PetrellaA., PauA., PinnaG. A., La CollaP.& other authors (2007; Synthesis and antiproliferative properties of N3/8-disubstituted 3,8-diazabicyclo[3.2.1]octane analogues of 3,8-bis[2-(3,4,5-trimethoxyphenyl)pyridin-4-yl]methyl-piperazine. Eur J Med Chem 42:293–306 [View Article][PubMed]
FilosaR., PedutoA., AparoyP., SchaibleA. M., LudererS., KrauthV., PetronziC., MassaA., de RosaM.& other authors (2013; Discovery and biological evaluation of novel 1,4-benzoquinone and related resorcinol derivatives that inhibit 5-lipoxygenase. Eur J Med Chem 67:269–279 [View Article][PubMed]
KeadleT. L., UsuiN., LaycockK. A., MillerJ. K., PeposeJ. S., StuartP. M.2000; IL-1 and TNF-α are important factors in the pathogenesis of murine recurrent herpetic stromal keratitis. Invest Ophthalmol Vis Sci 41:96–102[PubMed]
LenevaI. A., RussellR. J., BoriskinY. S., HayA. J.2009; Characteristics of arbidol-resistant mutants of influenza virus: implications for the mechanism of anti-influenza action of arbidol. Antiviral Res 81:132–140 [View Article][PubMed]
LuceyD. R., ClericiM., ShearerG. M.1996; Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases. Clin Microbiol Rev 9:532–562[PubMed]
MelchjorsenJ., SørensenL. N., PaludanS. R.2003; Expression and function of chemokines during viral infections: from molecular mechanisms to in vivo function. J Leukoc Biol 74:331–343 [View Article][PubMed]
Méndez-SamperioP., HernandezM., AyalaH. E.2000; Induction of transforming growth factor-β 1 production in human cells by herpes simplex virus. J Interferon Cytokine Res 20:273–280 [View Article][PubMed]
NicolaA. V., HouJ., MajorE. O., StrausS. E.2005; Herpes simplex virus type 1 enters human epidermal keratinocytes, but not neurons, via a pH-dependent endocytic pathway. J Virol 79:7609–7616 [View Article][PubMed]
PedutoA., MassaA., Di MolaA., de CaprariisP., La CollaP., LoddoR., AltamuraS., MagaG., FilosaR.2011; 2,3-Dihydro-1,2-Diphenyl-substituted 4H-Pyridinone derivatives as new anti Flaviviridae inhibitors. Chem Biol Drug Des 77:441–449 [View Article][PubMed]
RoizmanB., KnipeD. M.2001; Herpes simplex viruses and their replication. In Fields Virology, 4th edn. pp. 2399–2460 Edited by KnipeD. M., HowleyP. M. Philadelphia: Lippincott Raven Press;
SchaibleA. M., TraberH., TemmlV., NohaS. M., FilosaR., PedutoA., WeinigelC., BarzD., SchusterD., WerzO.2013; Potent inhibition of human 5-lipoxygenase and microsomal prostaglandin E2 synthase-1 by the anti-carcinogenic and anti-inflammatory agent embelin. Biochem Pharmacol 86:476–486 [View Article][PubMed]
SchelhaasM., JansenM., HaaseI., Knebel-MörsdorfD.2003; Herpes simplex virus type 1 exhibits a tropism for basal entry in polarized epithelial cells. J Gen Virol 84:2473–2484 [View Article][PubMed]
SellittoG., FaruoloA., de CaprariisP., AltamuraS., PaonessaG., CilibertoG.2010; Synthesis and anti-hepatitis C virus activity of novel ethyl 1H-indole-3-carboxylates in vitro. Bioorg Med Chem 18:6143–6148 [View Article][PubMed]
TeissierE., ZandomeneghiG., LoquetA., LavilletteD., LavergneJ. P., MontserretR., CossetF. L., BöckmannA., MeierB. H.& other authors (2011; Mechanism of inhibition of enveloped virus membrane fusion by the antiviral drug arbidol. PLoS ONE 6:e15874–e15880 [View Article][PubMed]
UsT., CetinE., KaşifoğluN., KaşifoğluT., AkgünY.2011; [Investigation of Epstein-Barr virus and herpes simplex virus markers by serological and molecular methods in patients with rheumatoid arthritis and systemic lupus erythematosus]. Mikrobiyol Bul 45:677–683 (in Turkish) [PubMed]
Zak-PrelichM., HallidayK. E., WalkerC., YatesC. M., NorvalM., McKenzieR. C.2001; Infection of murine keratinocytes with herpes simplex virus type 1 induces the expression of interleukin-10, but not interleukin-1α or tumour necrosis factor-α. Immunology 104:468–475 [View Article][PubMed]
In vitro antiviral and immunomodulatory activity of arbidol and structurally related derivatives in herpes simplex virus type 1-infected human keratinocytes (HaCat)